Bionxt Solutions Announces Convertible Debenture and Interest Settlement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR...
Day: November 24, 2023
Pierre Fabre Laboratories Collaborates With Chowis Company to Analyze Skin, Hair, and Scalp With AI Diagnostic Solutions
SEOUL, SOUTH KOREA / ACCESSWIRE / November 24, 2023 / Chowis Company ("Chowis"), a specialist in skin, hair and scalp...
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced the Company has received notice...
Cantargia Reports New Preclinical Data Confirming the Potential of Nadunolimab and CAN10
LUND, SE / ACCESSWIRE / November 24, 2023 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new...
Viasox Revolutionizes Diabetic Sock Market with Monthly Pattern Updates and a Mission to Aid Diabetics and Neuropathy Patients
MISSISSAUGA, ON / ACCESSWIRE / November 24, 2023 / Viasox, a dynamic company in the diabetic sock industry, is making...
Hologic to Showcase Developments in Next-Generation AI Solutions at RSNA 2023
Leader in Women’s Health Will Highlight New Imaging Solutions That Aid in Cancer Detection and Radiologist WorkflowMARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #genius3d--Hologic,...
New Hope for Children: SciSparc’s patented CBD- Enhanced Solution for Autism Spectrum Disorder
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
Safety Shot Continues Scientific Development with Double-Blind Placebo-Controlled Trial Designed to Assess the Effects of Safety Shot on Blood and Breath Alcohol Levels
Topline data expected Q1 2024Safety Shot is designed to make you feel good faster by reducing blood alcohol levels and...
NurExone Reports Third Quarter 2023 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company”...
Compass Pathways to participate in upcoming Evercore investor conference
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access...